Publications by authors named "R B Drummond"

The proneural transcription factor ASCL1 regulates neurogenesis and drives somatic cell reprogramming into neurons. However, not all cell types can be reprogrammed by ASCL1, raising the questions of what provides competence and how we can overcome barriers to enable directed differentiation. Here, we investigate how levels of ASCL1 and its phosphorylation modulate its activity over progressive lineage restriction of mouse embryonic stem cells.

View Article and Find Full Text PDF

Macrophages are critical components of the antifungal immune response. Disturbance in the number or function of these innate immune cells can significantly increase susceptibility to invasive fungal infections. Pathogenic fungi cause billions of infections every year and have an unmet clinical need, with many infections associated with unacceptably high mortality rates that primarily affect vulnerable patients with underlying immune defects.

View Article and Find Full Text PDF

Glucagon-like peptide-1 receptor agonists are peptide analogues that are used to treat type 2 diabetes mellitus and obesity. The first medication in this class, exenatide, was approved in 2005, and these medications, specifically semaglutide, have become more popular in recent years due to their pronounced effects on glycemic control, weight reduction, and cardiovascular health. Due to successful weight loss from these medications, many women previously diagnosed with oligomenorrhea and unable to conceive have experienced unplanned pregnancies while taking the medications.

View Article and Find Full Text PDF
Article Synopsis
  • PLX5622 is a small molecular inhibitor that targets the CSF1 receptor, primarily used to deplete macrophages in the central nervous system of C57BL/6 mice.
  • After one week of treatment, it was found to significantly reduce interstitial macrophages in the lungs and brains, leading to decreased infection from the fungus Cryptococcus neoformans.
  • The study highlights that while PLX5622 effectively reduces fungal lung infection, its impact relies on the presence of lymphocytes, as treatment does not alter fungal burden in lymphocyte-deficient mice.
View Article and Find Full Text PDF

Purpose: In contrast to the extensive literature on fear of cancer recurrence (FCR) experienced by adults, literature evaluating pediatric FCR has just begun to emerge. Given the rapidly expanding body of work assessing FCR in childhood and adolescence, a scoping review was conducted to synthesize existing findings. We aimed to assess (1) the characteristics and methods of this literature, (2) how pediatric FCR has been measured, and (3) the extant knowledge of FCR experienced by pediatric survivors of cancer.

View Article and Find Full Text PDF